ステチン療法と肝硬変におけるポータル圧縮: 系統的レビューとメタ解析
Eyad Abdulrazzak1, Butros Fakhoury2, Ali Jaan3
1Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
まとめ
スタチンは肝硬変とポータル高血圧患者の肝静脈圧グラデント (HVPG) をわずかに低下させる. これは,スタチンが非選択性ベータブロック剤 (NSBB) の有益な補足剤である可能性を示唆しています.
科学分野:
- ヘパトロジー
- 臨床薬理学
- 胃腸内科
背景:
- ポータル高血圧は肝硬変の補償不全の主な原因であり,罹病率と死亡率を増加させます.
- 非選択性ベータ阻害薬 (NSBB) は標準的な治療法ですが,最大45%の患者は適切なポータル圧縮を達成しません.
- スタチンは,ポータル高血圧の管理における潜在的な治療的役割について調査されています.
研究 の 目的:
- ランダム化制御試験 (RCT) を体系的にレビューし,メタ分析する.
- スタチンのポータル圧力 (HVPG) と肝硬変に関連するアウトカムへの影響を評価する.
- ポータル高血圧の潜在的補助療法としてスタチンを評価する.
主な方法:
- 肝硬変と臨床的に有意なポータル高血圧 (CSPH) を含む成人に関するRCTを5つのデータベースで検索した.
- 主要アウトカム:HVPGの減少 (絶対減少または血液動力学的反応).
- 副次的なアウトカム: の出血,アシテス,死亡率 ランダム効果のメタ分析が行われました.
主要な成果:
- 6つのRCT (n=492) では,スタチン療法によりHVPGが有意に低下 (MD: 1.1 mmHg) し,血液動力学的反応が増加 (RD: 0. 24) した.
- 血管新生出血,アシテス,または死亡率において有意な差異は観察されなかった.
- 短期フォローアップ研究でHVPGの利点が認められ,スタチンはNSBBに添加されるとHVPGをさらに低下させた.
結論:
- スタチンは,肝硬変に関連したポータル高血圧において,HVPGをわずかに減少させます.
- スタチンは,NSBBと併用すると,有益な補助療法として機能する.
- 長期的な効果と有効性を確認するには,より大規模な臨床試験が必要である.
さらに関連する動画
09:37Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
Published on: August 1, 2018
15.1K
04:00Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
Published on: November 15, 2024
309
関連する概念動画
01:28Esophageal Varices-II: Clinical Features and Management
135
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
135
01:24Esophageal Varices-I: Introduction
332
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
332
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
865
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
865
01:26Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
01:29Chronic Pancreatitis II: Collaborative Care
128
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
128
01:21Hepatic Portal System
2.1K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
2.1K